Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Amended Patent Law Could Facilitate Compulsory Licenses Of Pharmaceuticals – Patent Attorneys

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Leaders of China's national legislature are currently reviewing amendments to the patent law that could make it easier to force global pharmaceutical firms to license drugs to Chinese competitors in the event of a public health crisis
Advertisement

Related Content

China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs
China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs
Thailand Could Seek WTO Solution On Compulsory Licensing, Generic Drugs
Thailand Could Seek WTO Solution On Compulsory Licensing, Generic Drugs
U.S. Trade Rep’s IP Report: China Always Improving, Never Enough
U.S. Trade Rep’s IP Report: China Always Improving, Never Enough
China’s 2009 Regulatory Changes Affect Drug, API And Device Makers
China’s 2009 Regulatory Changes Will Affect Makers of Drugs, APIs and Devices
Insider Analysis From Jones Day: What Does the 3rd Amendment to China’s Patent Law Mean to Pharmaceutical Companies?
Insider Analysis From Jones Day: What Does the 3rd Amendment to China’s Patent Law Mean to Pharmaceutical Companies?
Advertisement
UsernamePublicRestriction

Register

SC069393

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel